About Reboxetine Mesilate
            
            Class: | Selective Norepinephrine Reuptake Inhibitor (NRI)  
Use: | Treatment of major depressive disorder (MDD) in adults  
Adult dose: | Initial dose of 4 mg once daily, may be increased to 8 mg once daily based on clinical response  
Pediatric dose: | Safety and efficacy not established in pediatric populations  
Side effects: | Common side effects include dry mouth, constipation, insomnia, dizziness, increased sweating, and nausea  
Contraindications: | Hypersensitivity to reboxetine or any 
         
        
            
                
                
                    
                        Drug Class
                    
                    Selective Norepinephrine Reuptake Inhibitor (NRI)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of major depressive disorder (MDD) in adults
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (15-30°C or 59-86°F), in a tightly closed container, protected from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Pharmacia & Upjohn S.p.A., ITALY
                    
                    
                    Package Size
                    20's Blister
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 34.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 4 mg once daily, may be increased to 8 mg once daily based on clinical response
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric populations
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include dry mouth, constipation, insomnia, dizziness, increased sweating, and nausea
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to reboxetine or any component of the formulation; concurrent use with monoamine oxidase inhibitors (MAOIs)
         
        
        
            
                Important Warnings
            
            Risk of suicidal thoughts and behaviors in young adults; monitor for worsening depression or emergence of suicidal thoughts; not recommended for use in patients with severe cardiovascular disorders or those with a history of seizures
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.